参考文献/References:
[1] Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002[J].JAMA,2006,295(18):2164-2167.
[2] Li X, Chen GP, Li L,et al. Dual effects of sodium aescinate on vascular tension in rat thoracic aorta[J].Microvasc Res,2010,79(1):63-69. DOI: 10.1016/j.mvr.2009.11.002.
[3] Wang Y, Ye Z, Hu X,et al. Morphological changes of the neural cells after blast injury of spinal cord and neuroprotective effects of sodium beta-aescinate in rabbits[J].Injury,2010,41(7):707-716. DOI: 10.1016/j.injury.2009.12.003.
[4] Du Y, Wang T, Jiang N,et al. Protective effect of sodium aescinate on lung injury induced by methyl parathion[J].Hum Exp Toxicol,2011,30(10):1584-1591.DOI:10.1177/0960327110393764.
[5] Wang XH, Xu B, Liu JT,et al. Effect of beta-escin sodium on endothelial cells proliferation, migration and apoptosis[J].Vascul Pharmacol,2008,49(4-6):158-165. DOI: 10.1016/j.vph.2008.07.005.
[6] Konoshima T, Lee KH. Antitumor agents, 82. Cytotoxic sapogenols from Aesculus hippocastanum[J].J Nat Prod,1986,49(4):650-656.
[7] 周雪莹,傅风华,李振,等. 七叶皂苷钠对宫颈癌瘤株株体内外增殖的抑制作用[J].烟台大学学报(自然科学与工程版), 2009,2(15):131-136.DOI:10.3969/j.issn.1004-8820.2009.02.012.
[8] 吴子侠,吴海竞,曹莉,等. 七叶皂苷体外抗SGC-7901细胞的作用及机制研究[J]. 中国药理学通报, 2009, 25(1): 78-81.DOI:10.3321/j.issn:1001-1978.2009.01.020.
[9] 竺佳,牛映平,徐佳,等. 七叶皂苷钠对P388小鼠白血病细胞的体内外增殖抑制作用[J]. 浙江工业大学学报, 2009, 32(2): 125-125. DOI:10.3969/j.issn.1006-4303.2009.02.002.
[10] 成志,高瑞兰,陈小红. 七叶皂苷诱导HL-60细胞凋亡的研究[J]. 中国实验血液学杂志, 2008, 16(2): 290-293.DOI:10.3969/j.issn.1009-2137.2008.02.012.
[11] 邹明,韩英,纪欣. 七叶皂甙钠抑制大肠癌HCT-8细胞生长及提高癌细胞对5-氟尿嘧啶敏感性的研究[J].中华消化杂志, 2001, 21(4): 248-249. DOI:10.3760/j.issn:0254-1432.2001.04.022.
[12] Patlolla JM, Raju J, Swamy MV,et al. Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1/cip1)in colon cancer cells[J].Mol Cancer Ther,2006,5(6):1459-1466.
[13] 杨晓冉,赵保忠,崔景荣. β-七叶皂苷钠对鸡胚血管新生的影响[J]. 中国新药杂志, 2006, 15(11): 868-870.DOI:10.3321/j.issn:1003-3734.2006.11.008.
[14] Rosen N, She QB. AKT and cancer--is it all mTOR?[J].Cancer Cell,2006,10(4):254-256.
[15] Manfredi GI, Dicitore A, Gaudenzi G,et al. PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy[J].Endocrine,2015,48(2):363-370. DOI: 10.1007/s12020-014-0380-1.
[16] Lim S, Kaldis P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation[J].Development,2013,140(15):3079-3093. DOI: 10.1242/dev.091744.
[17] 陈济,宋方州. CyclinE-CDK2分子活性调节机制[J].医学分子生物学杂志,2006, 3(3): 220-222. DOI:10.3870/j.issn.1672-8009.2006.03.014.